Virginia Retirement Systems Et Al Regenxbio Inc. Transaction History

Virginia Retirement Systems Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$29.09 - $45.68 $177,449 - $278,648	-6,100 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$32.46 - $40.48 $198,006 - $246,927	6,100 New	6,100 $237,000
Q1 2021 Apr 30, 2021	SELL	$33.61 - $49.95 $174,772 - $259,740	-5,200 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $137,904 - $256,620	5,200 New	5,200 $236,000
Q3 2019 Oct 22, 2019	SELL	$31.84 - $50.88 $133,728 - $213,696	-4,200 Closed	0 $0

Q2 2019 Jul 26, 2019	BUY	$42.0 - $59.29 $176,400 - $249,018	4,200 New	4,200 $216,000

193

42M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $458M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.